TY - JOUR
T1 - Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder
T2 - Moderation by childhood trauma severity
AU - Quidé, Yann
AU - Bortolasci, Chiara C.
AU - Spolding, Briana
AU - Kidnapillai, Srisaiyini
AU - Watkeys, Oliver J.
AU - Cohen-Woods, Sarah
AU - Carr, Vaughan J.
AU - Berk, Michael
AU - Walder, Ken
AU - Green, Melissa J.
PY - 2021/3/8
Y1 - 2021/3/8
N2 - Background: Elevated levels of systemic inflammation are consistently reported in both schizophrenia (SZ) and bipolar-I disorder (BD), and are associated with childhood trauma exposure. We tested whether childhood trauma exposure moderates associations between systemic inflammation and brain morphology in people with these diagnoses. Methods: Participants were 55 SZ cases, 52 BD cases and 59 healthy controls (HC) who underwent magnetic resonance imaging. Systemic inflammation was measured using a composite z-score derived from serum concentrations of interleukin 6, tumor necrosis factor alpha and C-reactive protein. Indices of grey matter volume covariation (GMC) were derived from independent component analysis. Childhood trauma was measured using the Childhood Trauma Questionnaire (CTQ Total score). Results: A series of moderated moderation analyses indicated that increased systemic inflammation were associated with increased GMC in the striatum and cerebellum among all participants. Severity of childhood trauma exposure moderated the relationship between systemic inflammation and GMC in one component, differently among the groups. Specifically, decreased GMC in the PCC/precuneus, parietal lobule and postcentral gyrus, and increased GMC in the left middle temporal gyrus was associated with increased systemic inflammation in HC individuals exposed to high (but not low or average) levels of trauma and in SZ cases exposed to low (but not average or high) levels of trauma, but not in BD cases. Conclusions: Increased systemic inflammation is associated with grey matter changes in people with psychosis, and these relationships may be partially and differentially moderated by childhood trauma exposure according to diagnosis.
AB - Background: Elevated levels of systemic inflammation are consistently reported in both schizophrenia (SZ) and bipolar-I disorder (BD), and are associated with childhood trauma exposure. We tested whether childhood trauma exposure moderates associations between systemic inflammation and brain morphology in people with these diagnoses. Methods: Participants were 55 SZ cases, 52 BD cases and 59 healthy controls (HC) who underwent magnetic resonance imaging. Systemic inflammation was measured using a composite z-score derived from serum concentrations of interleukin 6, tumor necrosis factor alpha and C-reactive protein. Indices of grey matter volume covariation (GMC) were derived from independent component analysis. Childhood trauma was measured using the Childhood Trauma Questionnaire (CTQ Total score). Results: A series of moderated moderation analyses indicated that increased systemic inflammation were associated with increased GMC in the striatum and cerebellum among all participants. Severity of childhood trauma exposure moderated the relationship between systemic inflammation and GMC in one component, differently among the groups. Specifically, decreased GMC in the PCC/precuneus, parietal lobule and postcentral gyrus, and increased GMC in the left middle temporal gyrus was associated with increased systemic inflammation in HC individuals exposed to high (but not low or average) levels of trauma and in SZ cases exposed to low (but not average or high) levels of trauma, but not in BD cases. Conclusions: Increased systemic inflammation is associated with grey matter changes in people with psychosis, and these relationships may be partially and differentially moderated by childhood trauma exposure according to diagnosis.
KW - C-reactive protein
KW - Childhood maltreatment
KW - Grey matter volume
KW - Interleukin 6
KW - Source-based morphometry
KW - Tumor necrosis factor alpha
UR - http://www.scopus.com/inward/record.url?scp=85086730772&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/386500
UR - http://purl.org/au-research/grants/NHMRC/630471
UR - http://purl.org/au-research/grants/NHMRC/1081603
UR - http://purl.org/au-research/grants/NHMRC/1061875
UR - http://purl.org/au-research/grants/NHMRC/1059660
UR - http://purl.org/au-research/grants/NHMRC/1156072
U2 - 10.1016/j.pnpbp.2020.110013
DO - 10.1016/j.pnpbp.2020.110013
M3 - Article
C2 - 32540496
AN - SCOPUS:85086730772
SN - 0278-5846
VL - 105
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
M1 - 110013
ER -